JENNIFER ROGERS: Open Payments
NPI 1508267097 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 5 payments from 5 companies in 2025. Trend: 2023 $1,285 · 2024 $64 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $115 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: REXULTI, INGREZZA, COBENFY, UZEDY, VRAYLAR.
Industry payments across GA — which companies pay providers there.
